Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ptc Therapeutics (PTCT) Return on Invested Capital: 2022-2025

Historic Return on Invested Capital for Ptc Therapeutics (PTCT) over the last 2 years, with Sep 2025 value amounting to -4.60%.

  • Ptc Therapeutics' Return on Invested Capital was N/A to -4.60% in Q3 2025 from the same period last year, while for Sep 2025 it was -4.60%, marking a year-over-year change of. This contributed to the annual value of 0.75% for FY2023, which is 612.00% down from last year.
  • As of Q3 2025, Ptc Therapeutics' Return on Invested Capital stood at -4.60%, which was down 33.11% from -3.46% recorded in Q2 2025.
  • In the past 5 years, Ptc Therapeutics' Return on Invested Capital registered a high of 1.79% during Q3 2022, and its lowest value of -4.60% during Q3 2025.
  • For the 3-year period, Ptc Therapeutics' Return on Invested Capital averaged around -0.50%, with its median value being 0.40% (2024).
  • Data for Ptc Therapeutics' Return on Invested Capital shows a maximum YoY crashed of 367bps (in 2025) over the last 5 years.
  • Quarterly analysis of 4 years shows Ptc Therapeutics' Return on Invested Capital stood at 1.77% in 2022, then plummeted by 122bps to 0.55% in 2023, then tumbled by 86bps to 0.21% in 2024, then plummeted by 367bps to -4.60% in 2025.
  • Its last three reported values are -4.60% in Q3 2025, -3.46% for Q2 2025, and -0.92% during Q1 2025.